|
Just down-river from me, Genzyme's Allston, MA drug manufacturing plant is shut down after a virus was found in one of the reactors. The facility produces drugs to treat Gaucher disease and Fabry disease, two rare genetic disorders. The nontechnical public in the area understands that a virus was found in the reactor, and that this is bad. There's general agreement that shutting down and decontaminating the plant is the correct response. But the more reporters try to explain how the bioreactors are designed to work, the more it sounds like a scheme by a mad scientist or an old horror flick. How can we explain complicated bioscience, and risks associated with them?
The preceding article is a "sneak peek" from Scientific Instruments, a newsletter from GlobalSpec. To stay up-to-date and informed on industry trends, products, and technologies, subscribe to Scientific Instruments today.
| 
